Arcturus Therapeutics Ltd. said its board decided to terminate the employment of President and CEO Joseph Payne.
The company said the decision is not related to the biotechnology company's operational performance, ongoing programs, financial condition or financial reporting.
Arcturus has named Mark Herbert as interim president, effective Feb. 2. Herbert joined the company in 2015 and most recently was vice president of business development and alliance management.
